This is a pilot study we call 'Making a difference together' aiming to:
Adolescence is a distinct neurodevelopmental period. While much of the adolescent literature focuses on the age group’s penchant for health risks and related behavior, recent research has shown that the adolescent brain is characterized by resilience, distinctive cognitive flexibility and social attunement. Further, adolescents are increasingly capable of and oriented towards contributing positively to their communities. Informed by this line of research, ADAPT is specifically articulated to the unique gifts and neurodevelopmental nature of the adolescent brain. The program consists of 3 group session and one parent meeting, that are specifically designed to bolster the strengths that adolescents naturally have within them, thereby supporting and empowering them to make meaningful and positive decisions, that will benefit their well-being and health (e.g., regarding alcohol use) and make a positive difference in their communities. By engaging a positive neurodevelopmental perspective with adolescents, ADAPT explores new ways of strengthening well-being and health in this age group.
The project is conducted in collaboration with a public school in Region Midtjylland and entails:
The project is being carried out from September 2021 to June 2023.
The project is funded by TrygFonden.
Throughout the study, the research team meets with an External Advisory Board, composed of experts on health promotion and prevention from practice, school principals, a representative from TrygFonden, and assistant professor Lotte Vallentin-Holbech. The purpose is to help the research team ensure quality, relevance and feasibility of the scientific project and the health promotion program.
Sarah Feldstein Ewing
Professor
University of Connecticut (UCONN) School of Medicine
Honorary Professor
Centre for Alcohol and Drug Research, Aarhus University